Sirtuin-1 expression and activity is diminished in aged liver grafts

Area of Science:

• Hepatology
• Transplantation immunology
• Mitochondrial biology

Background:

• Impaired function of aged liver grafts is a significant clinical challenge.
• Mitochondrial dysfunction is implicated in aged liver graft failure.
• Sirtuin1 (SIRT1) is crucial for mitochondrial recovery after ischemia-reperfusion injury.

Purpose of the Study:

• To compare sirtuin-1 expression and activity in aged versus young liver grafts.
• To correlate sirtuin-1 levels with mitochondrial function, metabolic capacity, and injury in liver grafts.
• To investigate the role of the sirtuin pathway in aged liver graft viability.

Main Methods:

• Rat liver grafts (old vs. young) underwent static cold storage and ex vivo reperfusion.
• Assessed sirtuin-1 expression, activity, mitochondrial function, and metabolic parameters.
• Evaluated graft injury through histological examination and inflammatory markers.

Main Results:

• Young liver grafts showed upregulated sirtuin-1 expression post-preservation and reperfusion; aged grafts did not.
• Aged grafts exhibited reduced tissue ATP, diminished antioxidant defense, and impaired metabolic function.
• No significant increase in inflammation or histological injury was observed in aged grafts compared to young grafts.

Conclusions:

• Diminished sirtuin-1 expression in aged liver grafts correlates with mitochondrial and metabolic dysfunction.
• The sirtuin pathway represents a potential therapeutic target for improving aged liver graft function.
• Targeting sirtuin may enhance the viability and efficacy of liver transplantation using older donor organs.